<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160228026817N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-10</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of the smell of breast milk and vanilla extract on the duration of the transition from gavage to oral feeding, weighing, and length of stay of premature infants</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of breast milk smell and vanilla extract on the duration of the transition from gavage to oral feeding, weighing, and length of stay of premature infants in special care units of hospitals affiliated with Shiraz University of Medical Sciences in 2023-2024</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>61</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69014</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: For randomization, the permuted block method will be used and people in three groups will be assigned to 10 blocks of 6. Allocation will be done by 
Random allocation software. In order to assign people to three groups, the intervention group with the scent of vanilla with the English letter A, the intervention group with the scent of mother's milk with the English letters B, and the control group with the English letters C are considered, and the different permutations of the ABC chain are written and given a code. The codes are CBA, CAB, BAC, ACB, ABC, and each time the groups are assigned, a number between 1 and 6 is randomly selected.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The duration of transition from gavage to oral feeding, weighing and length of stay of premature babies.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: Vanilla. In the present study, simultaneously with the start of gavage, olfactory stimulation was performed in the intervention group with a pad soaked in 1 cc of a concentration of 6 mg in 100 ccs of vanilla extract at 9 am, 12 noon, 3 pm, and 6 pm. Gavage is completed and olfactory stimulation is removed, which continues until the mother's breastfeeding begins. Intervention 2: The second intervention group:  is breast milk. In the present study, at the same time as the gavage begins, at 9:00 AM, 12:00 PM, 3:00 PM, and 6:00 PM, olfactory stimulation is performed and in the intervention group with a pad soaked in 1 cc of breast milk, and after the end of the gavage And the olfactory stimulus is removed, which continues until the start of feeding from the mother's breast. Intervention 3: Control group: In the present study, at the same time as the gavage begins, olfactory stimulation is performed in the intervention group with a pad soaked in 1 cc of sweet almond oil at 9 am, 12 noon, 3 pm, and 6 pm, and after the end of the gavage and The olfactory stimulation is removed, which continues until the mother's breastfeeding begins.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Jamalimoghadam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Namazee square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>+98 71 3647 4257</telephone>
        <email>nedajamali21@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Neda Jamalimoghadam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Namazee square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۱۱۹ - ۷۱۹۳۶</zip>
        <telephone>+98 71 3647 4257</telephone>
        <email>nedajamali21@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestational age 27-33 weeks (who have weakness and inability to suck)
Birth weight of at least 1 Kg
Apgar score greater than 6 in the first and fifth minutes
Not having any health-threatening congenital abnormalities
No underlying or acquired diseases except prematurity
Breast feeding</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>30 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Previous patient participation in studies similar to the current study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: Vanilla. In the present study, simultaneously with the start of gavage, olfactory stimulation was performed in the intervention group with a pad soaked in 1 cc of a concentration of 6 mg in 100 ccs of vanilla extract at 9 am, 12 noon, 3 pm, and 6 pm. Gavage is completed and olfactory stimulation is removed, which continues until the mother's breastfeeding begins.</i_keyword>
      <i_keyword>The second intervention group:  is breast milk. In the present study, at the same time as the gavage begins, at 9:00 AM, 12:00 PM, 3:00 PM, and 6:00 PM, olfactory stimulation is performed and in the intervention group with a pad soaked in 1 cc of breast milk, and after the end of the gavage And the olfactory stimulus is removed, which continues until the start of feeding from the mother's breast</i_keyword>
      <i_keyword>Control group: In the present study, at the same time as the gavage begins, olfactory stimulation is performed in the intervention group with a pad soaked in 1 cc of sweet almond oil at 9 am, 12 noon, 3 pm, and 6 pm, and after the end of the gavage and The olfactory stimulation is removed, which continues until the mother's breastfeeding begins.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The duration of the transition from gavage to oral feeding. Timepoint: The distance from the start of gavage feeding to oral feeding. Method of measurement: According to the patient's file.</prim_outcome>
      <prim_outcome>Weighing. Timepoint: Birth weight, weight at entry into the study, and weight at the time of feeding transfer. Method of measurement: Scale.</prim_outcome>
      <prim_outcome>Duration of Stay of premature babies. Timepoint: According to the patient's file. Method of measurement: Registration in the patient file.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Improving the quality of life. Timepoint: From admission to discharge. Method of measurement: The number of hospitalization days of infants in the intervention group is compared with the control group and recorded in the designed table.</sec_outcome>
      <sec_outcome>Decreasing parental anxiety. Timepoint: Birth weight, weight at the time of intervention, and weight at the time of discharge is measured. Method of measurement: Standard digital scale available in the department.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-29</approval_date>
        <contact_name>Ethics Committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Zand Street, in front of Palestine Street, Shiraz University of Medical Sciences Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
